期刊文献+

某院激素补充治疗用药监护药学门诊工作实践与效果 被引量:3

Working practice and effect of menopause and hormone replacement therapy in pharmaceutical care outpatient cilinc in a hospital
原文传递
导出
摘要 目的:介绍某院激素补充治疗(MHT)用药监护药学门诊工作实践与效果。方法:简述MHT用药监护药学门诊工作内容,收集2016年7月1日到2018年6月30日就诊的80例患者,分别于初诊时、MHT治疗1个月、3个月、12个月后对患者绝经相关症状、用药依从性进行评分,并统计年新增MHT用药率、MHT坚持用药率及不良反应发生情况。结果:完成随访患者73人,初诊时,MHT治疗1个月、3个月、12个月随访时的Kupperman评分随MHT用药时间的延长逐渐下降,用药依从性评分逐渐提高,差异均有统计学意义(与前次随访时比较,P<0.05);年新增MHT用药率20.00%,MHT 1年及以上坚持用药率41.10%;不良反应发生率15.07%,72.73%发生于MHT 3个月内,随访期间无乳腺癌等严重不良反应发生。结论:通过开设MHT用药监护药学门诊,临床药师在患者MHT治疗中发挥了积极的作用,证明了药学门诊服务的价值,为其他药学专科门诊的开展提供了参考。 OBJECTIVE To introduce the practice and effect of hormone replacement therapy(MHT) in pharmaceutical care outpatient department of our hospital. METHODS The contents of MHT pharmaceutical care pharmacy clinic were briefly described, and 80 patients who visited the clinic from July 1, 2016 to June 30, 2018 were collected. Menopause-related symptoms and medication compliance were scored at the time of initial diagnosis and after 1 month, 3 months, and 12 months of MHT treatment, respectively, and the annual rate of new MHT medication, MHT adherence medication rate, and incidence of adverse reactions were statistically analyzed. RESULTS 73 outpatients were followed up by their pharmacists. The kupperman score at the time of initial diagnosis, 1 month, 3 months and 12 months of MHT treatment gradually decreased with the extension of MHT medication, and the medication compliance score gradually increased, with statistically significant differences(compared with the previous follow-up, P<0.05);the annual rate of new MHT medication was 20.00%, and the rate of adherence to MHT for 1 year or more was 41.10%;The incidence of adverse reactions was 15.07%, of which 72.73% occurred within 3 months of MHT, and no serious adverse reactions such as breast cancer occurred during the follow-up period. CONCLUSION Clinical pharmacists play an active role in MHT by setting up MHT pharmaceutical care outpatient clinic, which proves the value of pharmaceutical outpatient service and provides a reference for the development of other pharmacy specialized outpatient clinics.
作者 李静静 虞燕霞 唐莲 李蓉 尚尔宁 陈久艳 LI Jing-jing;YU Yan-xia;TANG Lian;LI Rong;SHANG Er-ning;CHEN Jiu-yan(Department of Pharmacy, Suzhou Hospital Affiliated to Nanjing Medical University, Jiangsu Suzhou 215002, China;Department of Women's Health Care, Suzhou Hospital Affiliated to Nanjing Medical University, Jiangsu Suzhou 215002, China)
出处 《中国医院药学杂志》 CAS 北大核心 2019年第15期1586-1590,共5页 Chinese Journal of Hospital Pharmacy
基金 苏州市科技发展计划项目(编号:SYSD2018241,SYSD2010261)
关键词 MHT 药学监护 药学门诊 工作实践 MHT pharmaceutical care pharmacy clinic for outpatients working practice
  • 相关文献

参考文献5

二级参考文献41

  • 1田丰莲,杨冬梓,张小庄,赵庆国,詹新林,李容汉,穆荔,江雪芳,李洁明.广东地区围绝经期妇女健康状况和需求调查[J].第一军医大学学报,2004,24(8):928-932. 被引量:96
  • 2李芳莉.灸脐治疗女性更年期综合征的临床观察[J].中国针灸,2004,24(10):689-690. 被引量:22
  • 3徐苓,赵珩,葛秦生.围绝经期的流行病学调查[J].生殖医学杂志,1993,2(1):23-27. 被引量:105
  • 4程颖莲,莫端豪,练坚贞,宋平,罗红,张肇桂,王凯,赖光强.社区围绝经期妇女生存质量调查结果分析[J].中国妇幼保健,2007,22(14):1927-1929. 被引量:15
  • 5乐杰.妇产科学[M].北京:人民卫生出版社,2010:89.
  • 6卫生部继续医学教育委员会.女性生殖内分泌性激素补充疗法[J].北京:中国协和医科大学出版社,1999:8048.
  • 7Archer DF. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women [ J ]. Menopause,2001, 8 : 245-251.
  • 8Hulley SB, Grady D. The WHI estrogen-alone trial-do things look any better? [J]. JAMA,2004,291 (14) :1769-1771.
  • 9Hully S, Grady D, Bush T, et al. For the Heart and Estrogen/Progestin Replacement Study Research Group:randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women[J]. JAMA, 1998, 280:605-613.
  • 10Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women's Health Initiative randomized controlled trial[J].JAMA ,2002,288:321-333.

共引文献59

同被引文献63

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部